Does Hexarelin Need Refrigeration? Storage Guide

Research from independent pharmaceutical stability studies shows that peptides stored above 8°C for just 24 hours can lose up to 40% of their bioactive structure through protein denaturation. A degradation process that neither visual inspection nor at-home testing can detect. The question isn't whether hexarelin needs refrigeration; it's understanding exactly when, at what temperature, and for how long.

We've guided hundreds of research teams through peptide handling protocols. The gap between doing it right and doing it wrong comes down to three storage phases most guides never distinguish: pre-reconstitution, post-reconstitution, and transport.

Does hexarelin need refrigeration after mixing with bacteriostatic water?

Yes, hexarelin requires refrigeration at 2–8°C immediately after reconstitution with bacteriostatic water and must be used within 28 days. Unreconstituted lyophilised hexarelin stores at −20°C for maximum stability, while reconstituted solutions degrade rapidly at room temperature through peptide bond hydrolysis and oxidation.

The common error isn't forgetting to refrigerate. It's assuming lyophilised powder and reconstituted solution follow the same storage rules. Lyophilised hexarelin in its sealed vial tolerates short-term ambient temperature during shipping, typically up to 25°C for 48–72 hours without meaningful potency loss. Once you add bacteriostatic water, the stability window collapses. The reconstituted peptide is now in aqueous solution, where molecular movement accelerates degradation pathways that were dormant in the freeze-dried state. This article covers the exact temperature ranges for each storage phase, what happens at the molecular level when hexarelin is stored incorrectly, and the specific handling errors that negate stability even when refrigeration is used.

Why Temperature Control Dictates Hexarelin Stability

Hexarelin is a synthetic growth hormone-releasing peptide (GHRP) composed of six amino acids linked by peptide bonds. The same covalent bonds that hold all proteins together. These bonds are stable in solid lyophilised form but become vulnerable to hydrolysis once the peptide is dissolved in water. Hydrolysis is the chemical reaction where water molecules break peptide bonds, cleaving the amino acid chain into fragments that no longer bind to ghrelin receptors. The rate of hydrolysis doubles with every 10°C temperature increase, following the Arrhenius equation used to predict chemical reaction rates.

At 2–8°C (standard refrigeration), hydrolysis proceeds slowly enough that reconstituted Hexarelin maintains greater than 95% potency for 28 days. At 25°C (room temperature), that same solution loses approximately 10–15% potency within the first week and 30–40% within 21 days. By day 28, room-temperature storage leaves you with a solution that may retain only 50–60% of its original bioactivity. A concentration too degraded for reliable research outcomes.

Oxidation is the second degradation pathway. Hexarelin contains methionine, an amino acid with a sulfur-containing side chain that oxidizes when exposed to dissolved oxygen in bacteriostatic water. Oxidized methionine disrupts the peptide's three-dimensional structure, reducing its ability to bind to and activate ghrelin receptors in target tissues. Refrigeration slows oxidation by reducing molecular kinetic energy. The random motion that brings oxygen molecules into contact with methionine residues. Freezing the reconstituted solution at −20°C halts oxidation almost entirely, but introduces a new problem: ice crystal formation damages the peptide structure through mechanical shearing forces as water expands during freezing.

The research-backed storage protocol balances these competing degradation mechanisms. Store lyophilised hexarelin at −20°C to prevent any degradation. Once reconstituted, refrigerate at 2–8°C to minimize hydrolysis and oxidation without freezing. Use within 28 days because even under ideal refrigeration, cumulative oxidation and trace hydrolysis eventually reduce potency below acceptable research thresholds.

In our experience working with peptide researchers across hundreds of studies, the reconstitution step is where most storage errors occur. Not during long-term freezer storage. Researchers correctly store the lyophilised vial at −20°C, then leave the reconstituted solution at room temperature for hours while aliquoting doses. Those hours matter. A reconstituted vial sitting on a lab bench at 22°C for four hours before refrigeration has already begun measurable degradation.

What Happens When Hexarelin Need Refrigeration Requirements Are Ignored

Protein denaturation is the irreversible unfolding of a peptide's three-dimensional structure. Hexarelin's bioactivity depends on its specific shape. The spatial arrangement of amino acids that allows it to fit into ghrelin receptors like a key in a lock. Heat increases molecular vibration, disrupting the weak hydrogen bonds and hydrophobic interactions that hold the peptide in its active conformation. Once those bonds break, the peptide chain unfolds into a random coil that cannot activate receptors.

Denaturation begins at approximately 30°C for most aqueous peptide solutions and accelerates above 37°C. A reconstituted hexarelin vial left in a car on a warm day (interior temperature commonly exceeds 40°C within 30 minutes) can denature completely within 2–4 hours. The solution remains clear. There's no visible precipitation or color change to signal the damage. Visual inspection cannot detect denaturation. Potency testing via HPLC (high-performance liquid chromatography) or mass spectrometry would show fragmented peptides and loss of the intact molecular weight peak, but those assays aren't available at the bench level.

Bacterial contamination becomes a secondary risk when hexarelin need refrigeration protocols are violated. Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits bacterial growth but does not sterilize the solution. At refrigeration temperatures, bacterial growth is suppressed. At room temperature, the benzyl alcohol concentration is insufficient to prevent all microbial proliferation, particularly if the vial has been accessed multiple times with a needle. Each needle puncture introduces trace contaminants from the air and the needle surface. At 25°C, bacteria like Staphylococcus epidermidis or Bacillus species can double every 2–4 hours in aqueous peptide solutions. By 72 hours of room-temperature storage, microbial contamination can reach levels that cause cloudiness, odor, or visible particulates. Signs that the solution must be discarded.

The economic cost is straightforward. A 5mg vial of research-grade hexarelin costs approximately $60–$120 depending on the supplier. Room-temperature storage for one week reduces that vial's effective concentration by 15–25%, meaning you're injecting a 3.75–4.25mg-equivalent dose when your protocol calls for 5mg. To achieve the intended dose, you'd need to increase volume or order replacement vials more frequently. Both translate to wasted budget and inconsistent data.

The research integrity cost is harder to quantify but more significant. Peptide degradation isn't uniform across a study timeline. A vial reconstituted on Day 1 and stored at room temperature degrades steadily, meaning subjects dosed on Day 7 receive lower potency than subjects dosed on Day 1. This introduces an uncontrolled variable that confounds results. If you're studying hexarelin's effects on growth hormone release or muscle protein synthesis, degraded peptide produces weaker responses that could be misinterpreted as dose-response variation or subject variability rather than storage failure.

Does Hexarelin Need Refrigeration: Storage Phase Comparison

Understanding when hexarelin needs refrigeration requires distinguishing three distinct storage phases: lyophilised (unreconstituted), reconstituted, and during transport. Each phase has different temperature requirements and degradation risks.

The lyophilised phase offers the widest safety margin. Peptides in solid freeze-dried form are chemically inert because molecular movement is restricted. Water is the catalyst for hydrolysis and oxidation. Without it, degradation nearly stops. This is why manufacturers ship lyophilised hexarelin at ambient temperature with gel packs rather than dry ice. Short-term exposure to 20–25°C during 2–3 day shipping does not compromise a properly lyophilised peptide. The exception is prolonged heat: exposure above 30°C for more than 72 hours can cause enough residual moisture absorption to begin slow degradation even in lyophilised form.

Once reconstituted, the stability window collapses from months to weeks. The 28-day refrigerated shelf life is based on pharmaceutical stability testing showing that peptides in bacteriostatic water maintain >95% potency for four weeks at 2–8°C. Beyond 28 days, potency drops below 90%, and oxidation products accumulate. Some researchers extend usage to 35–40 days, accepting the incremental potency loss, but this introduces measurement uncertainty into dose-dependent studies.

Transport represents the highest-risk phase because temperature control depends on passive cooling rather than active refrigeration. Gel packs lose effectiveness after 12–18 hours depending on ambient temperature. A peptide vial in a soft-sided cooler with two gel packs will stay below 8°C for approximately 18–24 hours at 20°C ambient temperature, but only 8–12 hours at 30°C. This is why overnight shipping is standard for reconstituted peptides. Anything longer risks temperature excursions.

What If: Hexarelin Refrigeration Scenarios

What If I Left Reconstituted Hexarelin at Room Temperature Overnight?

Refrigerate it immediately and reduce your expected potency by approximately 5–8% for every 8-hour period at room temperature. A single overnight exposure (8–12 hours at 20–25°C) causes measurable but not catastrophic degradation. The solution remains usable but at slightly reduced concentration. If the vial was left out for 24 hours or more, consider it compromised for dose-sensitive research and either increase volume to compensate for estimated potency loss or discard and reconstitute a fresh vial. Do not assume the peptide is 'fine' because it looks clear. Hydrolysis and oxidation are invisible processes.

What If the Lyophilised Vial Arrived Warm After Shipping?

Lyophilised hexarelin tolerates short-term ambient temperature exposure during shipping without significant degradation. If the vial arrived at room temperature after 2–3 day shipping, place it in the freezer at −20°C immediately upon receipt and proceed with reconstitution as planned. The solid-state stability of lyophilised peptides provides a buffer against temperature fluctuations that reconstituted solutions do not have. The exception is if the package sat in a delivery truck or mailbox in direct sunlight for extended periods, reaching internal temperatures above 35°C for multiple days. In that scenario, contact the supplier for a replacement or request independent potency verification if your research protocol requires documented peptide integrity.

What If I Need to Transport Reconstituted Hexarelin for More Than 24 Hours?

Use a medical-grade cooler designed for pharmaceutical transport, pre-chill gel packs to 2–4°C (not frozen solid. Direct ice contact risks freezing the vial), and include a temperature data logger to document that the solution remained within 2–8°C throughout transport. For transport exceeding 24 hours, replace gel packs at the 18-hour mark or use an active cooling travel case with battery-powered refrigeration. Standard soft-sided lunch coolers are insufficient for peptide transport beyond 12 hours. If active cooling is unavailable and transport will exceed 24 hours, the safer protocol is to transport the lyophilised vial at ambient temperature and reconstitute at the destination rather than risk temperature excursions with a pre-mixed solution.

What If I Accidentally Froze the Reconstituted Hexarelin?

Discard it and reconstitute a new vial. Freezing reconstituted peptide solutions causes ice crystal formation that physically shears peptide chains and disrupts the three-dimensional structure required for receptor binding. Even partial freezing (ice formation around the vial edges with liquid center) compromises potency in unpredictable ways. Some researchers attempt to salvage frozen peptide by gentle thawing and mixing, but this introduces uncontrolled variability. Acceptable for preliminary screening work but unacceptable for dose-response studies or any research requiring precise quantification. The cost of replacing a $60–$120 vial is negligible compared to the cost of unreliable data from degraded peptide.

The Unforgiving Truth About Hexarelin Storage

Here's the honest answer: most peptide storage failures happen because researchers treat hexarelin like a stable small-molecule drug rather than a fragile protein. It isn't stable. The margin for error is narrow, and the degradation is silent. You won't see cloudiness, color change, or precipitation until bacterial contamination sets in, which is a separate failure mode that occurs after chemical degradation has already compromised potency. The reconstituted peptide in your refrigerator is degrading right now, even under perfect conditions, at a rate of approximately 0.2% per day. By day 28, cumulative losses approach the 5% threshold where dose accuracy becomes questionable.

The supplement industry has misled researchers and patients into believing peptides are chemically robust. They are not. A lyophilised vial stored correctly at −20°C is stable for years, but the moment you add water, you've started a countdown. Refrigeration at 2–8°C slows that countdown to 28 days. Room temperature accelerates it to 10–14 days before potency drops below acceptable research standards. Freezing the reconstituted solution doesn't extend the countdown. It breaks the peptide.

If your research protocol spans multiple weeks, reconstitute small batches rather than mixing a single large vial. A 5mg vial reconstituted to 1ml with bacteriostatic water yields a 5mg/ml solution. If your weekly dose is 500mcg (0.5mg), that vial contains ten weekly doses. Reconstituting the full vial gives you ten doses over 28 days, with the last dose potentially 10–15% weaker than the first. Reconstituting two 2.5mg vials separately. One at the start, one at week three. Keeps every dose within the first 14 days post-reconstitution, minimizing cumulative degradation.

Storage discipline isn't optional in peptide research. It's the baseline requirement for reproducible results. If you cannot maintain 2–8°C refrigeration, your data is compromised before the first injection. That's not a recommendation. It's biochemistry.

Peptide stability is where research rigor begins. Investigators working with compounds like BPC-157, Ipamorelin, or multi-peptide protocols face identical storage challenges. Every growth hormone-releasing peptide, every tissue repair compound, every peptide in aqueous solution follows the same degradation kinetics hexarelin does. The handling discipline you develop with one peptide transfers across your entire research program. At Real Peptides, we synthesize every batch with exact amino-acid sequencing and ship with temperature monitoring because we know storage failure negates everything that happens in the lab before the vial reaches you. You can explore high-purity research peptides designed for stability and consistency at our peptide collection, where small-batch synthesis meets the cold chain discipline serious research requires.

The vial in your freezer right now will perform exactly as designed if you store it correctly. The one you reconstituted last week has a 28-day window. And the one you left on the bench yesterday? That one's already teaching you the expensive lesson about why hexarelin needs refrigeration.